For site-specific cancers, the HMGCR gene region showed positive associations for five of the six most common cancer sites (breast, prostate, melanoma, lung, and bladder; not for bowel), although none of these results individually reached a conventional level of statistical significance. Here, HMGCR is linked to melanoma.